Page last updated: 2024-08-23

raloxifene hydrochloride and Libman-Sacks Disease

raloxifene hydrochloride has been researched along with Libman-Sacks Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ma, KM; Mok, CC; Wong, CK; Ying, SK	1
Gonzalez, J; Peeva, E; Pepeljugoski, KP; Rosenfeld, G; Saha, S; Zhang, Y	1
Ma, KM; Mak, A; Mok, CC; To, CH	1

Trials

2 trial(s) available for raloxifene hydrochloride and Libman-Sacks Disease

Article	Year
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial. Lupus, 2013, Volume: 22, Issue:14 Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Double-Blind Method; Estrogen Antagonists; Female; Follow-Up Studies; Glucocorticoids; Homocysteine; Humans; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Postmenopause; Prednisolone; Raloxifene Hydrochloride; Severity of Illness Index; Treatment Outcome	2013
Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study. Arthritis and rheumatism, 2005, Volume: 52, Issue:12 Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femur Neck; Humans; Lipids; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Pilot Projects; Postmenopause; Raloxifene Hydrochloride; Treatment Outcome	2005

Article

Year

Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.

Lupus, 2013, Volume: 22, Issue:14

Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Double-Blind Method; Estrogen Antagonists; Female; Follow-Up Studies; Glucocorticoids; Homocysteine; Humans; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Postmenopause; Prednisolone; Raloxifene Hydrochloride; Severity of Illness Index; Treatment Outcome

2013

Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.

Arthritis and rheumatism, 2005, Volume: 52, Issue:12

Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femur Neck; Humans; Lipids; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Pilot Projects; Postmenopause; Raloxifene Hydrochloride; Treatment Outcome

2005

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Libman-Sacks Disease

Article	Year
Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice. The Journal of rheumatology, 2010, Aug-01, Volume: 37, Issue:8 Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; B-Lymphocyte Subsets; CD40 Antigens; Cells, Cultured; DNA; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Estrogens; Female; Glomerular Mesangium; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred NZB; Ovariectomy; Raloxifene Hydrochloride; Spleen	2010

Article

Year

Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.

The Journal of rheumatology, 2010, Aug-01, Volume: 37, Issue:8

Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; B-Lymphocyte Subsets; CD40 Antigens; Cells, Cultured; DNA; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Estrogens; Female; Glomerular Mesangium; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred NZB; Ovariectomy; Raloxifene Hydrochloride; Spleen

2010